Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...

The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.

Novo Nordisk announced today that Health Canada has approved RYBELSUS® (semaglutide tablets) to reduce the risk of major ...

Researchers have found in a new study that consumption of millet-based foods may improve glycemic response and ...

Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...

One in Three Middle-Aged Europeans Will Develop Diabetes in Lifetime Progression to prediabetes, type 2 diabetes, and insulin use is alarming in middle-aged European adults with normal glucose, and ...

ACC INVEST: Deaths up at Lowest BP Diabetic patients whose systolic blood pressure was lowered to 130 to 140 mm Hg had a better outcome than those with systolic pressures over 140. But reductions ...

ENDO 2019 PIONEER-3: Oral Semaglutide Shows Benefit in Type 2 Diabetes Higher doses of oral semaglutide reduce HbA1c better than sitagliptin in type 2 diabetes but has more gastrointestinal side ...

A research team at the Max Planck Institute for Metabolism Research has found that the smell of fatty foods during pregnancy increases the risk of overweight and obesity in children. The researchers ...